Ignite Creation Date:
2025-12-24 @ 11:50 PM
Ignite Modification Date:
2025-12-31 @ 12:30 PM
Study NCT ID:
NCT04998851
Status:
COMPLETED
Last Update Posted:
2025-08-21
First Post:
2021-08-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study Evaluating B Cell Levels In Infants Of Lactating Women With CIS Or MS Receiving Ocrelizumab
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-09-16
Start Date Type:
ACTUAL
Primary Completion Date:
2024-03-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-01-13
Completion Date Type:
ACTUAL
First Submit Date:
2021-08-06
First Submit QC Date:
None
Study First Post Date:
2021-08-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-03-26
Results First Submit QC Date:
None
Results First Post Date:
2025-04-16
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-20
Last Update Post Date:
2025-08-21
Last Update Post Date Type:
ACTUAL